INT MEDICAL (01501): Wang Ruiqin resigned as a non-executive director of the company.
Yingtai Medical (01501) announced that Mr. Wang Ruiqin has resigned as a non-executive director of the company due to personal work arrangement adjustments, effective from August 24, 2026 (the date on which the company received the resignation notice).
INT MEDICAL (01501) announced that Mr. Wang Ruiqin has submitted his resignation as a non-executive director of the company due to personal work arrangement adjustments, effective from August 24, 2026 (the date the company received the resignation notice).
Mr. Jian Xigao and Mr. Xu Hongqun have served as independent non-executive directors of the company since December 8, 2018, and their continuous tenure has exceeded seven years. The company is currently preparing for its initial public offering of ordinary shares (A-shares) and listing. According to the regulations in the "Measures for the Administration of Independent Directors of Listed Companies" and other relevant laws and regulations concerning A-shares, independent non-executive directors may not serve more than six consecutive years. In light of the fact that Mr. Jian Xigao and Mr. Xu Hongqun have surpassed the aforementioned regulatory limit, and to comply with the listing requirements for A-shares, as well as considering their personal work arrangement adjustments, Mr. Jian Xigao and Mr. Xu Hongqun have applied to resign from their positions as independent non-executive directors and members of the board's specialized committees. Their resignation will be effective from the date when the new independent non-executive directors officially assume their positions.
After considering the recommendations from the nomination committee, the board has resolved to recommend Dr. Zhang Peng and Dr. Li Yunlong as candidates for independent non-executive directors of the fourth board. The appointment of the independent non-executive directors is still subject to approval by shareholders at a temporary shareholders' meeting through an ordinary resolution and will take effect from the date of such approval.
According to the companys articles of association, the company will hold the 11th meeting of the second employee representative assembly on August 24, 2026, to elect Ms. Chen Jie as an employee representative director of the fourth board, who will form the fourth board together with other directors, with a term starting from the date of her election until the expiration of the fourth board's term.
Related Articles

JIMU GROUP (08187) issued a profit warning, expecting a comprehensive net loss of approximately HKD 6.5 million for the first half of the year, an increase of about 66.7% year-on-year.

SUN.KING TECH (00580) released its interim results, reporting a loss attributable to shareholders of approximately 26.742 million yuan, a turnaround from profit to loss compared to the same period last year.

S.F. Holding (06936) plans to invest up to 305 million yuan to subscribe for shares in Fengchao, deepening its strategic layout in last-mile logistics.
JIMU GROUP (08187) issued a profit warning, expecting a comprehensive net loss of approximately HKD 6.5 million for the first half of the year, an increase of about 66.7% year-on-year.

SUN.KING TECH (00580) released its interim results, reporting a loss attributable to shareholders of approximately 26.742 million yuan, a turnaround from profit to loss compared to the same period last year.

S.F. Holding (06936) plans to invest up to 305 million yuan to subscribe for shares in Fengchao, deepening its strategic layout in last-mile logistics.

RECOMMEND





